Results 101 to 110 of about 40,178 (264)

Regional anesthesia in total cystectomy - our experience

, 1994
Regional anesthesia in total cystectomy is one of the methods. The aim of this study is to estimate whether this method increases bleeding during radical urinary bladder ...
Cindrić-Stančin, M., Šustić, Alan, Krstulović, B.   +2 more
core   +1 more source

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy

Acta Oncologica
Background and purpose: Recommended treatment of urothelial muscle-invasive bladder cancer (MIBC) is cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy, but there are challenges with low utilization of NAC.
Hege S. Haugnes, Hakon Kjaeve, Eivind Bjerkaas, Ragnhild Hellesnes, Line Hjelle, Magnus Larsen   +5 more
doaj   +1 more source

O‐GlcNAcylation of KAT2A Enhances Bladder Cancer Proliferation by Inhibiting the KAT2A‐TRIM22 Interaction

Cancer Science, EarlyView.
Lysine acetyltransferase 2A (KAT2A) is a transcriptional coactivator and a member of the Histone Acetyltransferase (HAT) family. While altered KAT2A activity has been implicated in various cancers, its role in bladder cancer (BLCA) remains poorly understood.
Wenjie Yang, Zhaoheng Jin, Ziyi Li, Weifeng Xu, Yingjie Li, Yueqiang Peng, Jie Dong, Lin Ma, Zhigang Ji   +8 more
wiley   +1 more source

Perioperative Complications and In-hospital Mortality After Cystectomy for Nonbladder Cancer Conditions Versus Radical Cystectomy for Bladder Cancer

Objective: This study was designed to test for perioperative complications, mortality, and length of stay after cystectomy for nonbladder cancer (non-BCa) v radical cystectomy (RC) for bladder cancer (BCa).
Siech, Carolin, Karakiewicz, Pierre I., Goyal, Jordan A., Saad, Fred, Briganti, Alberto, Puliatti, Stefano, Chun, Felix K. H., Di Bello, Francesco, de Angelis, Mario, Longo, Nicola, Micali, Salvatore, Rodriguez Peñaranda, Natali, Tian, Zhe, Shariat, Shahrokh F., Di Bari, Stefano   +14 more
core   +1 more source

KPNA2 Drives Immunosuppression in Ovarian Cancer via CCL2/CCR2‐Dependent MDSC Recruitment

Cancer Science, EarlyView.
KPNA2 drives intratumoral MDSC accumulation and immunosuppression in ovarian cancer via the NF‐κB/CCL2/CCR2 axis. Mechanistically, KPNA2 facilitates NF‐κB/p65 nuclear translocation and induces CCL2 transcription, recruiting MDSCs to establish an immunosuppressive microenvironment.
Qingli Li, Jitong Zhao, Lu Yang, Lin Li, Ce Bian, Tao Yi, Huiqiong Huang, Gang Zheng, Xiaojuan Lin   +8 more
wiley   +1 more source

International Radical Cystectomy Consortium: A way forward

, 2014
Robot-assisted radical cystectomy (RARC) is an emerging operative alternative to open surgery for the management of invasive bladder cancer. Studies from single institutions provide limited data due to the small number of patients.
Lee Richstone, Douglas S. Scherr, Adam S. Kibel, Peabody, James O, Poulakis, Vassilis, Wilson, Timothy, Erinn Field, Guan Wu, Stoeckle, Micheal, John G. Pattaras, Scherr, Douglas S, Menon, Mani, Mathew Hayn, Wu, Guan, Hayn, Mathew, James O. Peabody, Khan, Shamim, Mani Menon, Guru, Khurshid A, Ghavamian, Reza, Koauk, Jihad, AlonZ. Weizer, Raza, Syed Johar, Andrew Wagner, Maatman, Thomas, Pattaras, John G, Alex Mottrie, Syed Johar Raza, JamesO. Peabody, M.Derya Balbay, Prokar Dasgupta, Field, Erinn, Dasgupta, Prokar, AshokK. Hemal, Balbay, M Derya, Koon-Ho Rha, Francis Schanne, Raj Pruthi, Timothy Wilson, Redorta, Joan Palou, Peter Wiklund, Mottrie, Alex, Micheal Stoeckle, Khurshid A. Guru, Rha, Koon-Ho, Wiklund, Peter, Weizer, Alon Z, Hemal, Ashok K, DouglasS. Scherr, Joan Palou Redorta, JohnG. Pattaras, Greg Wilding, Kibel, Adam S, Reza Ghavamian, AdamS. Kibel, Schanne, Francis, Thomas Maatman, Jihad Koauk, Wagner, Andrew, Richstone, Lee, M. Derya Balbay, Wilding, Greg, JoanPalou Redorta, Siemer, Stephan, Pruthi, Raj, KhurshidA. Guru, Gaboardi, Franco, Alon Z. Weizer, Franco Gaboardi, Stephan Siemer, Ashok K. Hemal, SyedJohar Raza, Shamim Khan, Vassilis Poulakis   +73 more
core   +1 more source

Marked attenuation of P63 expression in plasmacytoid urothelial carcinoma with expanded immunohistochemical framework including E‐cadherin, P120, HER2 and TRPS1

Histopathology, EarlyView.
Plasmacytoid urothelial carcinoma demonstrates marked attenuation of p63 expression together with frequent disruption of the E‐cadherin–p120 adhesion complex, supporting its characteristic discohesive growth pattern. Standardized HER2 scoring identifies a substantial positive subset, highlighting diagnostic pitfalls and potential therapeutic relevance ...
Busra Yaprak Bayrak, Kemal Kosemehmetoglu, Busra Ozbek, Sercan Simsek, Murat Oktay, Ganime Coban, Dilara Irem Arslan Kahraman, Egemen Akıncıoglu, Melek Buyukgok, Selin Colak, Hatice Nese Dogan, Burak Gurel, Selva Kabul, Kerem Karaca, Elif Ozsagir, Ece Ozturk, Havva Serap Toru, Gupse Turan, Nazif Alperen Yıldırım, Ozlem Nur Yıldız, Yasemin Yuyucu Karabulut, Liang Cheng, Mahmut Akgul   +22 more
wiley   +1 more source

Partial Cystectomy for Muscle-Invasive Bladder Cancer

Partial cystectomy is a surgical bladder-sparing option for selected patients with muscle-invasive bladder cancer (MIBC), urachal adenocarcinoma and diverticular bladder tumors. Partial cystectomy hold several advantages. It allows for definite pathology
Peter S. Palencia, Nethusan Sivanesan, Hesse, David, Palencia, Peter S, Lee, Byron H, Sivanesan, Nethusan, Tan, Wei-Shen, Wei-Shen Tan, John Colberg, Syed Rahman, Ashwin Sridhar, Ashish M. Kamat, Sridhar, Ashwin, Fady Ghali, Kamat, Ashish M, Kelly, John D, David Hesse, Ghali, Fady, Colberg, John, John D. Kelly, Byron H. Lee, Rahman, Syed   +21 more
core   +1 more source

Cost of cystectomy-related complications in patients with bladder cancer in the United States

, 2020
Aims: To describe healthcare utilization and cost associated with the short-term and long-term complications of cystectomy among commercially insured bladder cancer patients in the United States.
Elisabetta Malangone-Monaco (8739594), Kathleen Wilson (361295), Sarika Ogale (6813422), Sacha Satram (8739603), Darren Tayama (8739600), David Diakun (8739597)   +5 more
core   +1 more source

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source